Safety and Efficacy Study of Ozurdex® Compared to Lucentis® in Patients With Branch Retinal Vein Occlusion

NCT01427751 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

307

Enrollment

INDUSTRY

Sponsor class

Conditions

Retinal Vein Occlusion
Macular Edema

Interventions

DRUG: dexamethasone intravitreal implant
BIOLOGICAL: ranibizumab

Sponsor

Allergan